Breaking News, Promotions & Moves

Pathalys Pharma Names Bastian Dehmel as Chief Medical Officer

Dr. Dehmel brings 20 years of global biotechnology and pharmaceutical industry experience.

Author Image

By: Charlie Sternberg

Associate Editor

Pathalys Pharma, Inc., a private biopharmaceutical company in the late stages of developing treatments for kidney disease, has appointed Bastian Dehmel, M.D. as its Chief Medical Officer.   Dehmel will assume responsibility for clinical operations, clinical affairs, clinical sciences, data management/biometrics, and product drug safety.  He will report to Neal Fowler, Pathalys CEO, and will serve on the Senior Leadership Team.   “We are thrilled to welcome Bastian as Pathalys’ Ch...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters